Licensing, Mergers & Acquisitions

Reverse Mergers

  • Geller Biopharm has successfully executed reverse merger transactions for its clients.
  • The ideal reverse merger combines a private company with an exciting product and/or platform with a public company with cash or trading near or below cash.
  • A reverse merger can also target a non-biotech company or "Form 10" shell with no cash, along with concomitant financing.
  • Traditionally, reverse mergers have been viewed somewhat negatively, compared to IPO's, however, their image has improved. Cougar has demonstrated that reverse mergers can be highly successful.
  • Overall, this is a viable strategy, especially in a period when the IPO window is closed.
Geller Biopharm

  Broker / Dealer services provided by Pickwick Capital Partners, LLC. Member FINRA / SIPC

Download our presentation

Get a digital copy of our PDF presentation

Download PDF